The Manufacturers Life Insurance Company Has $54.82 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

The Manufacturers Life Insurance Company cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 0.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,751,408 shares of the company’s stock after selling 7,653 shares during the quarter. The Manufacturers Life Insurance Company owned about 1.03% of Option Care Health worth $54,819,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of OPCH. Massachusetts Financial Services Co. MA acquired a new position in shares of Option Care Health in the 2nd quarter valued at approximately $68,003,000. Victory Capital Management Inc. lifted its stake in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after acquiring an additional 1,585,818 shares in the last quarter. Magnetar Financial LLC lifted its stake in Option Care Health by 124.8% in the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after acquiring an additional 1,377,929 shares in the last quarter. Duquesne Family Office LLC lifted its stake in Option Care Health by 172.8% in the 2nd quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after acquiring an additional 1,185,613 shares in the last quarter. Finally, Geneva Capital Management LLC bought a new stake in Option Care Health in the 3rd quarter valued at approximately $24,679,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.64% of the stock is owned by company insiders.

Option Care Health Trading Up 0.1 %

Shares of Option Care Health stock opened at $23.76 on Friday. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63. The stock has a market cap of $4.04 billion, a P/E ratio of 19.97, a P/E/G ratio of 2.42 and a beta of 1.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business’s 50 day moving average is $27.00 and its 200-day moving average is $28.93.

Analyst Upgrades and Downgrades

Several research firms have commented on OPCH. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Barrington Research cut their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, JMP Securities upped their price objective on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.